Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness of Paliperidone ER(Invega®) on Depressive Symptoms of Schizophrenia Patients: A 8-week Open-label Prospective, Non-comparative Study

NCT01399450 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.

NCT NCT01399450
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01399450 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness of Paliperidone ER(Invega®) on Depressive Symptoms of Schizophrenia Patients: A 8-week Open-label Prospective, Non-comparative Study
Lead sponsor
Seoul National University Hospital
Phase
Phase 4
Overall status
Completed
Start date
August 31, 2011
Completion date
November 30, 2016
Enrollment
11 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia